The PoET® Multiscreen PCR kit allows simultaneous detection and differentiation of HCV, HBV, and HIV.

PoET® Multiscreen has received IVDR certification, clearing the path for its commercial rollout.

FRANKFURT, Germany — Addressing the critical need for enhanced blood safety, GFE, a well-established provider in NAT Solutions for blood safety based in Germany, is proud to introduce the PCR kit PoET® Multiscreen.

As a state-of-the-art multiplex assay for nucleic acid amplification technology (NAT), this new kit offers laboratory professionals and clinicians a certified high level of accuracy and ease of use.

PoET® Multiscreen features include:

• Multiplex Assay: Enabling simultaneous detection and differentiation of HCV, HBV, and HIV in one assay.
  
• Multi-target viral detection: uses multi-target and overlapping designs to guarantee maximum sensitivity, inclusivity, and tolerance to viral mutations.
  
• Seamless Integration: Designed for use with PoET® Instrument, ensuring streamlined lab operations and optimized workflows.

1. Quality control simplification: PoET® Universal Positive Control
   The PoET® Universal Positive Control kit is designed to work in tandem with the PoET® Multiscreen PCR kit. It’s primary function is to replace virus-specific controls with a single reagent capable of validating all viral detections.

• Process Efficiency: Minimizes the complexity of reagent management.
  
• Validation Integrity: Ensures uniform performance standards across the entire assay menu.
  
• Cost & Time Savings: Reduces the number of control runs required for result verification.

The latest iteration of the Calliope® software introduces three key functionalities aimed at high-throughput environments:

Throughput Optimization
(‘Staggered Run’): Technicians can now initiate a subsequent run while the previous one is still in progress. This overlapping workflow can increase a single device output by up to 50 % in 8 hours.

Site-Wide Monitoring (Dashboard): Provides a centralized interface to monitor the status and results of every PoET® Instrument connected to a local network.”

Frankfurt am Main 2026-07-22